Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Real-life Post-marketing Observational Study Assessing the Effectiveness of Upadacitinib for Treating Rheumatoid Arthritis (CLOSEUP)

NCT04574492 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04574492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04574492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Real-life Post-marketing Observational Study Assessing the Effectiveness of Upadacitinib for Treating Rheumatoid Arthritis (CLOSEUP)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
October 7, 2020
Completion date
July 30, 2024
Enrollment
413 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)